Evidence map›Paper›PMID 34382938›Full record

ArticleeLife2021

A genetic intervention.

Colin Sutherland, Didier Menard

Open access · goldAbstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. A systematic review and meta-analysis on sub-microscopicThe Lancet regional health. Southeast Asia · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Colin SutherlandDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0003-1592-6407
Didier MenardMalaria Genetics and Resistance Unit, INSERM U1201, Paris, France.ORCID 0000-0003-1357-4495
Inserm · FR

Funding

Medical Research Council G0600718Medical Research Council MR/T016124/1
6 · The paper itself

Abstract

A tool that analyzes the genome of parasites found in the blood of malaria patients can help inform policy decisions on how best to tackle the rise in drug-resistant infections.

Indexed as

AntimalarialsMalariaGenetic EngineeringGenetic TherapyHumansPlasmodium falciparumAntimalarialsAsiadrug resistanceepidemiologygenetic surveillanceglobal healthinfectious diseasemalariamicrobiologyP. falciparum

Identifiers

PMID34382938
PMCPMC8360649
OpenAlexW3187886799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.